Apellis Pharmaceuticals Inc (APLS)
27.98
+0.72
(+2.64%)
USD |
NASDAQ |
Nov 01, 16:00
27.97
-0.01
(-0.04%)
After-Hours: 20:00
Apellis Pharmaceuticals Price to Book Value: 12.89 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 12.89 |
| October 31, 2024 | 12.56 |
| October 30, 2024 | 12.76 |
| October 29, 2024 | 12.63 |
| October 28, 2024 | 12.59 |
| October 25, 2024 | 12.29 |
| October 24, 2024 | 12.71 |
| October 23, 2024 | 12.43 |
| October 22, 2024 | 12.71 |
| October 21, 2024 | 12.38 |
| October 18, 2024 | 12.90 |
| October 17, 2024 | 12.86 |
| October 16, 2024 | 12.88 |
| October 15, 2024 | 12.88 |
| October 14, 2024 | 12.61 |
| October 11, 2024 | 12.50 |
| October 10, 2024 | 12.29 |
| October 09, 2024 | 12.39 |
| October 08, 2024 | 12.62 |
| October 07, 2024 | 12.65 |
| October 04, 2024 | 12.67 |
| October 03, 2024 | 12.93 |
| October 02, 2024 | 13.12 |
| October 01, 2024 | 12.78 |
| September 30, 2024 | 13.29 |
| Date | Value |
|---|---|
| September 27, 2024 | 13.58 |
| September 26, 2024 | 13.75 |
| September 25, 2024 | 14.09 |
| September 24, 2024 | 14.17 |
| September 23, 2024 | 15.07 |
| September 20, 2024 | 14.98 |
| September 19, 2024 | 16.92 |
| September 18, 2024 | 16.41 |
| September 17, 2024 | 16.37 |
| September 16, 2024 | 16.73 |
| September 13, 2024 | 17.33 |
| September 12, 2024 | 16.94 |
| September 11, 2024 | 17.67 |
| September 10, 2024 | 18.05 |
| September 09, 2024 | 18.40 |
| September 06, 2024 | 18.91 |
| September 05, 2024 | 18.10 |
| September 04, 2024 | 17.40 |
| September 03, 2024 | 17.87 |
| August 30, 2024 | 17.92 |
| August 29, 2024 | 17.84 |
| August 28, 2024 | 17.59 |
| August 27, 2024 | 18.24 |
| August 26, 2024 | 18.35 |
| August 23, 2024 | 18.48 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
7.220
Minimum
Apr 01 2020
101.13
Maximum
Jun 14 2021
27.01
Average
20.48
Median
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.345 |
| Ionis Pharmaceuticals Inc | 23.18 |
| EyePoint Pharmaceuticals Inc | 2.827 |
| Cassava Sciences Inc | 6.654 |
| Macrogenics Inc | 4.198 |
Price to Book Value Related Metrics
| PS Ratio | 5.433 |
| Price | 27.98 |
| Earnings Yield | -9.79% |
| Market Cap | 3.407B |